Public-private partnership (3Ps) in ensuring safe use of medicines: An Indian experience

• Prif Awduron: Vivekanandan Kalaiselvan (Awdur), Shatrunajay Shukla (Awdur), Shubhang Arora (Awdur), Tarani Prakash Shrivastava (Awdur), Rajeev Singh Raghuvanshi (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Frontiers Media S.A., 2022-08-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Adverse drug reactions (ADRs) are major concerns to the public health. To monitor ADRs and ensure patients' safety, the Pharmacovigilance Programme of India (PvPI) has been established by the Government of India in 2010. The programme is intact with the Public-Private Partnership (3Ps) in pharm...